MarketInOut Stock Screener Log In | Sign Up
 

Jupiter Neurosciences Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 07/21/2026 16:00
Jupiter Neurosciences Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization8.32 mln
Float22.50 mln
Earnings Date08/19/2026

Piotroski F-Score

4 / 9
Borderline

Relative Strength

5 / 100
Severely lagging

Debt / Equity

-1.74
Negative equity

ROE

-6,529
Deeply negative

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Business Description

Jupiter Neurosciences is a pharmaceutical company based in Jupiter, Florida, focused on developing treatments for brain and nervous system diseases using a compound called resveratrol. The company currently has five drug candidates in Phase II clinical trials, targeting conditions such as Friedreich's Ataxia, early Alzheimer's disease, Parkinson's disease, and two other rare neurological disorders. Beyond prescription treatments, Jupiter Neurosciences also works with partners to create consumer health products aimed at healthy aging and longevity.

Key Fundamentals

EPS-0.26
ROE-6,529
RPS0.00
ROIC-200
ROA-218
EBITDA, mln-8.99
EV / EBITDA-1.78
EV / EBIT-1.78
Revenue, mln0.04
EV / Revenue390

Financial Strength

Altman Z-Score-20.33
Piotroski F-Score 4 / 9
Short Ratio0.24
Short % of Float2.72

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.66% 16 / 100   
1 Month -28.7% 7 / 100   
2 Months -57.47% 4 / 100   
6 Months -80.24% 3 / 100   
1 Year -89.52% 4 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us